Are you at the 2010 BIO International Convention? Life Technologies is presenting in four panels today, looking at clinical trials in the age of genomics, bioethics, and patents and patient care in the age of personalized medicine.

Tuesday, May 4, 2010 - 2:00-3:30 p.m.
Clinical Trials in the Genomics Age
Conference: Breakout Sessions
Track: Exciting Science 2010
Location: McCormick Place, Chicago
Room: S405B
Genetic sequencing technologies are driving down the costs of sequencing the entire human genome, but to what end? And how will economical DNA sequencing affect the quest to find more effective medicines? Join sequencing technology experts, pharmaceutical company leaders, and translational researchers in a discussion of how nextgeneration sequencing technologies are affecting drug discovery and facilitating the identification and validation of predictive biomarkers.
- Michael Hadjisavas - Chair Vice President, Business Development
- Mark Stevenson - MBA, President and Chief Operating Officer

Tuesday, May 4, 2010 - 2:00-3:30 p.m.
Bioethics: Synonymous With Good Business
Conference: Breakout Sessions
Track: Impact on Policy in Biobusiness
Location: McCormick Place, Chicago
Room: N427A
Biotechnology and its applications often raise controversial bioethics issues. Over the years, companies have developed internal and external strategies for addressing these issues responsibly. Hear how leading companies describe their process and policies and provide recommendations to others in industry who are looking for successful approaches on bioethics. - John Skousen - Chair Compliance Officer

Tuesday, May 4, 2010 - 4:00-5:30 p.m.
It’s Personal - Transforming Health Care Through Personalized Medicine Conference: Breakout Sessions
Track: Devices and Predictive Diagnostics
Location: McCormick Place, Chicago
Room: S402A
Personalized medicine is making a real difference for patients every day. It holds the promise to improve health outcomes—and could save the health care system billions of dollars annually. How is the industry bringing molecular medicine and targeted therapies closer to reality? Hear experts from multiple pieces of the personalized medicine puzzle, including tool companies, large pharmaceutical corporations, and pharmacy benefit managers, discuss where we are now and what we need to do to accelerate our progress.
- Linh Hoang, MD Director, Personalized Medicine

Tuesday, May 4, 2010 - 4:00-5:30 p.m.
Patents for Personalized Medicine Products—Considerations and Pitfalls for the Unwary
Conference: Breakout Sessions
Track: Legal/Intellectual Property
Location: McCormick Place, Chicago
Room: S404D
The personalized medicine industry stands to greatly benefit from patent protection. Relevant legal issues—such as those relating to “subject matter” patentability, written description/enablement requirements, and obviousness— impact this area. An understanding of U.S. case law will guide companies as they pursue, enforce, and/or license patents covering their products. Although U.S. law is in a state of flux regarding certain legal issues, careful specification and claim drafting can help avoid obvious pitfalls. The lecture will discuss legal cases, such as In re Bilski (Fed. Cir. 2008) and Prometheus Labs. (Fed. Cir. 2009), now pending at the Supreme Court (subject matter patentability); Ariad Pharms recently argued en banc at the Federal Circuit (written description/“possession” requirement); and KSR (S. Ct. 2007) (obviousness) and its aftermath.
- AJ Bokal - Lead IP Counsel, Genetic Systems Division